- Home
- Industry Reports
- Healthcare
- Pharmaceuticals
- Clinical Trial Management System Market – Share, Outlook, Trends, Size and Forecast (2024 – 2032)
Global Clinical Trial Management System Market is expected to reach $2.45 billion by the end of 2024 growing at a CAGR of around 12.8% from 2018 to 2024. A clinical trial management system (CTMS) is a system used by Pharmaceutical and Biotechnology industries to manage clinical trials in clinical research. The system maintains and oversees the planning, performing and reporting functions, along with participant contact information, tracking deadlines and many more.
Global Clinical Trial Management System Market Share:
Based on Mode of Delivery, Web-based sub-segment will represent a significant market, expanding at a robust CAGR of 15.2%. Based on a component, software sub-segment will attain a value of US$ 1.28 Billion by the end of the forecast period. The pharmaceutical industry is the most significant end-user of clinical trial management systems, and CROs sub-segment is expected to register the fastest CAGR throughout the forecast period.
Global Clinical Trial Management System Market Size:
North America will remain a dominant segment and expand at a CAGR of nearly 13.8%. This regional market was valued at US$ 1.3 Billion in 2018 and is predicted to reach US$ 1.9 Billion by 2024 end. As the clinical trial market has gradually been shifting to the Asia Pacific due to several legal and regulatory measures, and patent expiration laws. China and India are expected to grow into lucrative markets for clinical trial management systems. The European market will also reflect significant growth.
Global Clinical Trial Management System Market Growth:
Increasing prevalence of chronic diseases will spur the demand for effective and efficient management of data, documentation, and hospital information within medical organisations. This is expected to be a key factor propelling the growth of the CTMS market. The increasing number of healthcare service providers and exploding number of healthcare end-users will further accelerate CTMS adoption in the market. High accuracy of the information provided by clinical trial management systems is foreseen to be a significant driver of market growth.
Global Clinical Trial Management System Market Industry Analysis:
On basis of Delivery Mode, The market is segmented into Web-based Clinical Trial Management System, On-Premise Clinical Trial Management System and Cloud-based Clinical Trial Management System. On basis of Components, The market is segmented into Software, Hardware and Services. On basis of End User, The market is segmented into Pharmaceuticals & Biotechnology Companies and Healthcare Providers: Research Hospitals, Clinics, Academic Medical Centres and Cancer Centres. On basis of Type, The market is segmented into Site based Clinical Trial Management System and Licensed Enterprise based Clinical Trial Management System. On basis of Applications, The market is segmented into Patient Management Solutions, Site Management Solutions, Data Management Solutions and Document Management Solutions and By Region, it is segmented into North America, Europe, Asia Pacific and Rest of the World.
Global Clinical Trial Management System Market Outlook:
Integration of Hospital information system (HIS) and Clinical trial management system enables accurate documentation. The emergence of global clinical organisations provides users with most relevant and specific information by maintaining a centralised clinical trial management database.
Global Clinical Trial Management System Market Trends:
Forte, an industry-leading developer of clinical research solutions, has been named to the 2017 Best Places to Work by Madison Magazine. Forte is ranked third of the top 10 largest companies. Bio-Optronics and Complion Announced the Integration to Unify Best-in-Class CTMS and eRegulatory Solutions for Clinical Research Organizations.
Global Clinical Trial Management System Market Research report includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Bio-Optronics
- Merge Healthcare
- Forte Research Systems
- Parexel
- BioClinica
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Delivery Mode
6.1 Cloud-based Clinical Trial Management System
6.2 On-Premise Clinical Trial Management System
6.3 Web-based Clinical Trial Management System
Chapter 7 Market Segmentation, By Components
7.1 Services
7.2 Hardware
7.3 Software
Chapter 8 Market Segmentation, By End-User
8.1 Healthcare Providers
8.1.1 Cancer Centres
8.1.2 Academic Medical Centres
8.1.3 Clinics
8.1.4 Research Hospitals
8.2 Pharmaceuticals & Biotechnology Companies
Chapter 9 Market Segmentation, By Type
9.1 Licensed Enterprise based Clinical Trial Management System
9.2 Site based Clinical Trial Management System
Chapter 10 Market Segmentation, By Applications
10.1 Document Management Solutions
10.2 Data Management Solutions
10.3 Site Management Solutions
10.4 Patient Management Solutions
Chapter 11 Market Segmentation, By Geography
11.1 North America
11.1.1 Introduction
11.1.2 United States
11.1.3 Canada
11.1.4 Mexico
11.1.5 Others
11.2 Europe
11.2.1 Introduction
11.2.2 U.K
11.2.3 Spain
11.2.4 Italy
11.2.5 France
11.2.6 Russia
11.2.7 Others
11.3 Asia-Pacific
11.3.1 Introduction
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 Australia
11.3.6 Others
11.4 South America
11.4.1 Introduction
11.4.2 Brazil
11.4.3 Argentina
11.4.4 Others
11.5 The Middle East & Africa
11.5.1 Introduction
11.5.2 South Africa
11.5.3 Others
Chapter 12 Competitive Landscape
12.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
12.2 Market Share Analysis
12.3 Strategies Adopted By Top Companies
Chapter 13 Company Profiles
13.1. Omnicomm Systems
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Benchmarking
13.1.4. Strategic Initiative
13.2. DSG
13.3. Parexel
13.4. Bio-Optronics
13.5. Medidata
13.6. Forte Research Systems
13.7. BioClinica
13.8. Sparta Systems
13.9. Merge Healthcare
13.10. Oracle
13.11. eClinForce Inc.
13.12. VEEVA Systems Inc.
13.13. DATATRAK International Inc.
13.14. MedNet Solutions
13.15. Aris Global, LLC
Chapter 14 Market Estimates and Forecast
14.1 Market Estimates and Forecast 2018-2024(USD Million)
14.1.1 Market Estimation and Forecast by Delivery Mode 2018-2024 (USD Million)
14.1.2 Market Estimation and Forecast by Components 2018-2024 (USD Million)
14.1.3 Market Estimation and Forecast by End User 2018-2024 (USD Million)
14.1.4 Market Estimation and Forecast by Type 2018-2024 (USD Million)
14.1.5 Market Estimation and Forecast by Applications 2018-2024 (USD Million)
14.1.6 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 15 Market Insights
15.1 Insights of Industry Experts
15.2 Analyst Opinion (Market Understanding)
15.3 Investment Opportunities
Chapter 16 Appendix
16.1 List of Tables
16.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,489.86 - €7,469.57
- INR: ₹225,053.86 - ₹675,161.59
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,133.43 - £6,400.30
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Global Clinical Trial Management System Market is expected to reach $2.45 billion by the end of 2024 growing at a CAGR of around 12.8% from 2018 to 2024. A clinical trial management system (CTMS) is a system used by Pharmaceutical and Biotechnology industries to manage clinical trials in clinical research. The system maintains and oversees the planning, performing and reporting functions, along with participant contact information, tracking deadlines and many more.
Global Clinical Trial Management System Market Share:
Based on Mode of Delivery, Web-based sub-segment will represent a significant market, expanding at a robust CAGR of 15.2%. Based on a component, software sub-segment will attain a value of US$ 1.28 Billion by the end of the forecast period. The pharmaceutical industry is the most significant end-user of clinical trial management systems, and CROs sub-segment is expected to register the fastest CAGR throughout the forecast period.
Global Clinical Trial Management System Market Size:
North America will remain a dominant segment and expand at a CAGR of nearly 13.8%. This regional market was valued at US$ 1.3 Billion in 2018 and is predicted to reach US$ 1.9 Billion by 2024 end. As the clinical trial market has gradually been shifting to the Asia Pacific due to several legal and regulatory measures, and patent expiration laws. China and India are expected to grow into lucrative markets for clinical trial management systems. The European market will also reflect significant growth.
Global Clinical Trial Management System Market Growth:
Increasing prevalence of chronic diseases will spur the demand for effective and efficient management of data, documentation, and hospital information within medical organisations. This is expected to be a key factor propelling the growth of the CTMS market. The increasing number of healthcare service providers and exploding number of healthcare end-users will further accelerate CTMS adoption in the market. High accuracy of the information provided by clinical trial management systems is foreseen to be a significant driver of market growth.
Global Clinical Trial Management System Market Industry Analysis:
On basis of Delivery Mode, The market is segmented into Web-based Clinical Trial Management System, On-Premise Clinical Trial Management System and Cloud-based Clinical Trial Management System. On basis of Components, The market is segmented into Software, Hardware and Services. On basis of End User, The market is segmented into Pharmaceuticals & Biotechnology Companies and Healthcare Providers: Research Hospitals, Clinics, Academic Medical Centres and Cancer Centres. On basis of Type, The market is segmented into Site based Clinical Trial Management System and Licensed Enterprise based Clinical Trial Management System. On basis of Applications, The market is segmented into Patient Management Solutions, Site Management Solutions, Data Management Solutions and Document Management Solutions and By Region, it is segmented into North America, Europe, Asia Pacific and Rest of the World.
Global Clinical Trial Management System Market Outlook:
Integration of Hospital information system (HIS) and Clinical trial management system enables accurate documentation. The emergence of global clinical organisations provides users with most relevant and specific information by maintaining a centralised clinical trial management database.
Global Clinical Trial Management System Market Trends:
Forte, an industry-leading developer of clinical research solutions, has been named to the 2017 Best Places to Work by Madison Magazine. Forte is ranked third of the top 10 largest companies. Bio-Optronics and Complion Announced the Integration to Unify Best-in-Class CTMS and eRegulatory Solutions for Clinical Research Organizations.
Global Clinical Trial Management System Market Research report includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Bio-Optronics
- Merge Healthcare
- Forte Research Systems
- Parexel
- BioClinica
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Delivery Mode
6.1 Cloud-based Clinical Trial Management System
6.2 On-Premise Clinical Trial Management System
6.3 Web-based Clinical Trial Management System
Chapter 7 Market Segmentation, By Components
7.1 Services
7.2 Hardware
7.3 Software
Chapter 8 Market Segmentation, By End-User
8.1 Healthcare Providers
8.1.1 Cancer Centres
8.1.2 Academic Medical Centres
8.1.3 Clinics
8.1.4 Research Hospitals
8.2 Pharmaceuticals & Biotechnology Companies
Chapter 9 Market Segmentation, By Type
9.1 Licensed Enterprise based Clinical Trial Management System
9.2 Site based Clinical Trial Management System
Chapter 10 Market Segmentation, By Applications
10.1 Document Management Solutions
10.2 Data Management Solutions
10.3 Site Management Solutions
10.4 Patient Management Solutions
Chapter 11 Market Segmentation, By Geography
11.1 North America
11.1.1 Introduction
11.1.2 United States
11.1.3 Canada
11.1.4 Mexico
11.1.5 Others
11.2 Europe
11.2.1 Introduction
11.2.2 U.K
11.2.3 Spain
11.2.4 Italy
11.2.5 France
11.2.6 Russia
11.2.7 Others
11.3 Asia-Pacific
11.3.1 Introduction
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 Australia
11.3.6 Others
11.4 South America
11.4.1 Introduction
11.4.2 Brazil
11.4.3 Argentina
11.4.4 Others
11.5 The Middle East & Africa
11.5.1 Introduction
11.5.2 South Africa
11.5.3 Others
Chapter 12 Competitive Landscape
12.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
12.2 Market Share Analysis
12.3 Strategies Adopted By Top Companies
Chapter 13 Company Profiles
13.1. Omnicomm Systems
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Benchmarking
13.1.4. Strategic Initiative
13.2. DSG
13.3. Parexel
13.4. Bio-Optronics
13.5. Medidata
13.6. Forte Research Systems
13.7. BioClinica
13.8. Sparta Systems
13.9. Merge Healthcare
13.10. Oracle
13.11. eClinForce Inc.
13.12. VEEVA Systems Inc.
13.13. DATATRAK International Inc.
13.14. MedNet Solutions
13.15. Aris Global, LLC
Chapter 14 Market Estimates and Forecast
14.1 Market Estimates and Forecast 2018-2024(USD Million)
14.1.1 Market Estimation and Forecast by Delivery Mode 2018-2024 (USD Million)
14.1.2 Market Estimation and Forecast by Components 2018-2024 (USD Million)
14.1.3 Market Estimation and Forecast by End User 2018-2024 (USD Million)
14.1.4 Market Estimation and Forecast by Type 2018-2024 (USD Million)
14.1.5 Market Estimation and Forecast by Applications 2018-2024 (USD Million)
14.1.6 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 15 Market Insights
15.1 Insights of Industry Experts
15.2 Analyst Opinion (Market Understanding)
15.3 Investment Opportunities
Chapter 16 Appendix
16.1 List of Tables
16.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.